Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1150893

	registered interest
	date	21/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the (a) diagnosis, (b) treatment and (c) support provided to people with secondary breast cancer.
	tabling member constituency	Birkenhead
	tabling member printed	Frank Field
	uin	2689
	answer	answer is ministerial correction date of answer 28/10/2019 answer text <p>In September 2019 we announced funding of £200 million for new equipment to drive earlier diagnosis of cancer and improve survival. More than 300 diagnostic machines will be funded across the country, replacing outdated MRI machines, CT scans and breast screening equipment with cutting edge technology.</p><p>The NHS Long Term Plan sets a clear ambition that where appropriate ever person diagnosed with cancer should have access to personalised care by 2021. Personalised care is made up of four interventions that used to be referred to as the Support Package:</p><p>- Personalised care and support planning based on holistic needs assessments;</p><p>- End of treatment summaries;</p><p>- Health and wellbeing information and support; and</p><p>- A Cancer Care Review with their general practitioner.</p><p>The NHS Cancer Programme aims to improve access to cancer Clinical Nurse Specialists (CNS) for all cancer patients when they need it, including those with secondary breast cancer. The NHS Long Term Plan commitment is that all patients, including those with secondary cancers, will have access to the right expertise and support, including a CNS or other support worker by 2021.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 28/10/2019 15:45:53 answering member 4380 label Biography information for Jo Churchill
	tabling member	478 label Biography information for Lord Field of Birkenhead

1150905

	registered interest
	date	21/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cystic Fibrosis: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of waiving tax on generic versions of lifesaving cystic fibrosis drugs entering the UK from Argentina on the (a) quality of life and (b) wellbeing of people with cystic fibrosis.
	tabling member constituency	Portsmouth South
	tabling member printed	Stephen Morgan
	uin	2907
	answer	answer is ministerial correction date of answer 28/10/2019 answer text <p>The Department has made no such assessment. The United Kingdom’s Government policy is that there is no VAT on drugs prescribed by a qualified professional. HM Treasury keeps all taxes under review but there are no plans to extend the zero rate to other products at this time. Our priority is to ensure that patients have access to medicines which are certified as safe and effective, and which are affordable for the National Health Service. We welcome the announcement of Orkambi.</p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 28/10/2019 15:44:51 answering member 4380 label Biography information for Jo Churchill previous answer version 1546 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
	tabling member	4653 label Biography information for Stephen Morgan

1150840

	registered interest
	date	21/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Human Papillomavirus: Northern Ireland
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with the Department of Health, Social Services and Public Safety in Northern Ireland on the introduction of HPV Primary Screening in Northern Ireland.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	2728
	answer	answer is ministerial correction date of answer 28/10/2019 answer text <p>The Secretary of State for Health and Social Care has not had any direct discussion with the Department of Health in Northern Ireland on the introduction of human papillomavirus (HPV) primary screening in this jurisdiction.</p><p>The Northern Ireland Screening Committee has agreed a programme of work to be led by the Northern Ireland Public Health Agency during 2019/20 to inform the development of a policy paper on introducing HPV testing in Northern Ireland cervical screening for consideration by the Department of Health in Northern Ireland in 2020.</p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 2729 question first answered 28/10/2019 15:52:12 answering member 4380 label Biography information for Jo Churchill
	tabling member	4131 label Biography information for Jim Shannon

1150841

	registered interest
	date	21/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Human Papillomavirus: Northern Ireland
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment has he made of the potential merits of the introduction of HPV primary screening in Northern Ireland.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	2729
	answer	answer is ministerial correction date of answer 28/10/2019 answer text <p>The Secretary of State for Health and Social Care has not had any direct discussion with the Department of Health in Northern Ireland on the introduction of human papillomavirus (HPV) primary screening in this jurisdiction.</p><p>The Northern Ireland Screening Committee has agreed a programme of work to be led by the Northern Ireland Public Health Agency during 2019/20 to inform the development of a policy paper on introducing HPV testing in Northern Ireland cervical screening for consideration by the Department of Health in Northern Ireland in 2020.</p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 2728 question first answered 28/10/2019 15:52:12 answering member 4380 label Biography information for Jo Churchill
	tabling member	4131 label Biography information for Jim Shannon

1150848

	registered interest
	date	21/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Human Papillomavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what progress he has made on extending the HPV vaccine to boys.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	2734
	answer	answer is ministerial correction date of answer 28/10/2019 answer text <p>We extended the human papillomavirus vaccination programme to adolescent boys in year 8 from September 2019 and this is currently being rolled out across the country for the 2019-20 academic year.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 28/10/2019 15:46:38 answering member 4380 label Biography information for Jo Churchill
	tabling member	4131 label Biography information for Jim Shannon